Brian D. Friend

515 total citations
18 papers, 220 citations indexed

About

Brian D. Friend is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Brian D. Friend has authored 18 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Hematology. Recurrent topics in Brian D. Friend's work include Childhood Cancer Survivors' Quality of Life (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Brian D. Friend is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Brian D. Friend collaborates with scholars based in United States, Sweden and Singapore. Brian D. Friend's co-authors include Noah Federman, Bita V. Naini, Xiaoyan Zhou, Ronald W. Busuttil, Hanlin Wang, Robert S. Venick, Sue V. McDiarmid, Douglas G. Farmer, Gary J. Schiller and Christopher C. Dvorak and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Pharmacology.

In The Last Decade

Brian D. Friend

15 papers receiving 218 citations

Peers

Brian D. Friend
Monica Arenas-Hernandez United Kingdom
Collier Ireland
N. Maillard France
Christine-Elke Ortmann Switzerland
S. LATOUR Canada
David Choi United States
Francisco J. Márquez‐Malaver Spain
John O’Regan Ireland
Amrith Mathew India
Johanna Konopacki France
Monica Arenas-Hernandez United Kingdom
Brian D. Friend
Citations per year, relative to Brian D. Friend Brian D. Friend (= 1×) peers Monica Arenas-Hernandez

Countries citing papers authored by Brian D. Friend

Since Specialization
Citations

This map shows the geographic impact of Brian D. Friend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Friend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Friend more than expected).

Fields of papers citing papers by Brian D. Friend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian D. Friend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Friend. The network helps show where Brian D. Friend may publish in the future.

Co-authorship network of co-authors of Brian D. Friend

This figure shows the co-authorship network connecting the top 25 collaborators of Brian D. Friend. A scholar is included among the top collaborators of Brian D. Friend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian D. Friend. Brian D. Friend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Puri, Kriti, Luci Corrêa, Brian D. Friend, et al.. (2025). Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatric Blood & Cancer. 72(4). e31557–e31557.
2.
Marron, Thomas U., et al.. (2024). Phase 1 study of ASP1002, a bispecific antibody targeting claudin 4 (CLDN4) and CD137, in patients with locally advanced (LA) or metastatic solid tumors that express CLDN4.. Journal of Clinical Oncology. 42(16_suppl). TPS2670–TPS2670. 1 indexed citations
3.
Friend, Brian D., et al.. (2024). “Just let me go”; When suicidal ideation and goals of care collide in adolescent cancer at the end of life. Pediatric Blood & Cancer. 71(6). e30893–e30893.
4.
Friend, Brian D., Ibrahim N. Muhsen, Shreeya Patel, et al.. (2022). Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplantation. 57(4). 579–585. 1 indexed citations
5.
Keizer, Ron J., et al.. (2021). Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation. Frontiers in Pharmacology. 12. 750672–750672. 6 indexed citations
6.
Friend, Brian D., Ghadir Sasa, Bilal Omer, et al.. (2021). Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children’s Hospital experience. Bone Marrow Transplantation. 56(11). 2797–2803. 4 indexed citations
7.
Friend, Brian D. & Gary J. Schiller. (2021). Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adults. Blood Reviews. 52. 100886–100886. 1 indexed citations
8.
9.
Qayed, Muna, Kwang Woo Ahn, Carrie L. Kitko, et al.. (2020). A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation. Blood. 137(7). 983–993. 18 indexed citations
10.
Friend, Brian D., Kami Wolfe Schneider, Timothy Garrington, et al.. (2019). Is polycystic kidney disease associated with malignancy in children?. Molecular Genetics & Genomic Medicine. 7(7). e00725–e00725. 4 indexed citations
11.
Friend, Brian D., Christine S. Higham, Jasmeen Dara, et al.. (2019). The Impact of Total Body Irradiation-Based Regimens on Outcomes in Children and Young Adults with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(3). S197–S198. 2 indexed citations
12.
Friend, Brian D., Alexis Melton, Kristin A. Shimano, et al.. (2019). The impact of total body irradiation‐based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 67(2). e28079–e28079. 17 indexed citations
13.
Friend, Brian D., et al.. (2019). Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature. Journal of Pediatric Hematology/Oncology. 42(6). e521–e526. 5 indexed citations
14.
Friend, Brian D., Kevin Tang, Daniela Markovic, et al.. (2019). Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 66(12). e27940–e27940. 8 indexed citations
15.
Friend, Brian D. & Gary J. Schiller. (2017). Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults. Blood Reviews. 32(2). 122–129. 9 indexed citations
16.
Friend, Brian D., Gary J. Schiller, Jonathan Bergman, et al.. (2017). Clinical trial enrollment of adolescent and young adult patients with cancer: a systematic review of the literature and proposed solutions. Volume 6. 51–59. 13 indexed citations
17.
Friend, Brian D., Robert S. Venick, Sue V. McDiarmid, et al.. (2017). Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma. Pediatric Blood & Cancer. 64(12). 106 indexed citations
18.
Fischer, Ryan T., Brian D. Friend, Geoffrey A. Talmon, et al.. (2013). Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency. Pediatric Transplantation. 18(2). 190–196. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Arenas-Hernandez Breakdown of academic impact, for papers by Collier Breakdown of academic impact, for papers by N. Maillard Breakdown of academic impact, for papers by Christine-Elke Ortmann Breakdown of academic impact, for papers by S. LATOUR Breakdown of academic impact, for papers by David Choi Breakdown of academic impact, for papers by Francisco J. Márquez‐Malaver Breakdown of academic impact, for papers by John O’Regan Breakdown of academic impact, for papers by Amrith Mathew Breakdown of academic impact, for papers by Johanna Konopacki
Rankless by CCL
2026